全球卒中管理市场规模、份额、趋势和成长分析报告（2026-2034年）

预计中风治疗市场将从 2025 年的 493.8 亿美元成长到 2034 年的 959.6 亿美元，2026 年至 2034 年的复合年增长率为 7.66%。

随着全球中风病例的不断增加，全球中风管理市场也稳步扩张。这主要是由于人口老化、不健康的生活方式以及高血压和糖尿病盛行率的上升。早期诊断和及时介入对于中风治疗至关重要，这也推动了对先进影像系统、溶栓药物和神经血管介入器材的需求。

关键成长要素包括微创手术技术的进步和急救回应系统的改进。远端医疗和远端监测解决方案的引入提高了获得专业中风护理的机会，尤其是在农村地区。政府为提高公众对卒中的认识和实施预防计划而采取的措施也进一步促进了市场成长。

未来几年，神经保护药物和人工智慧诊断工具的创新可望提升治疗效果。新兴市场医疗基础设施的不断改善将创造更多成长机会。随着人们对早期症状识别的认识不断提高，对综合性中风管理解决方案的需求预计将持续增长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球卒中管理市场：依类型划分

• 市场分析、洞察与预测
• 诊断
• 透过治疗方法

第五章 全球卒中管理市场：依应用领域划分

• 市场分析、洞察与预测
• 缺血性中风
• 出血性中风

第六章 全球卒中管理市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Aidoc
  • JLK
  • Deepnoid Co. Ltd
  • VasSol Inc
  • B. Braun SE
  • Cardinal Health
  • Siemens AG
  • Medtronic
  • NeuraSignal Inc
  • Abbott Laboratories
  • METHINKS
  • Boston Scientific Corporation
  • Merck & Co. Inc
  • Heuron Co. Ltd
  • Bristol-Myers Squibb Company

The Stroke Management Market size is expected to reach USD 95.96 Billion in 2034 from USD 49.38 Billion (2025) growing at a CAGR of 7.66% during 2026-2034.

The global stroke management market is expanding steadily due to the rising incidence of stroke cases worldwide. Increasing aging populations, unhealthy lifestyles, and growing prevalence of hypertension and diabetes are major contributing factors. Early diagnosis and timely intervention are critical in stroke treatment, leading to higher demand for advanced imaging systems, thrombolytic drugs, and neurovascular devices.

Major growth drivers include technological advancements in minimally invasive surgical procedures and improved emergency response systems. The adoption of telemedicine and remote monitoring solutions has enhanced access to specialized stroke care, particularly in rural regions. Government initiatives focused on stroke awareness and prevention programs further strengthen market growth.

In the coming years, innovation in neuroprotective drugs and AI-based diagnostic tools is expected to enhance treatment outcomes. Expanding healthcare infrastructure in emerging economies will create additional growth avenues. As awareness about early symptom recognition increases, the demand for comprehensive stroke management solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Diagnostics
• Therapeutics

By Application

• Ischemic Stroke
• Haemorrhagic Stroke

COMPANIES PROFILED

• Aidoc, JLK, Deepnoid Co Ltd, VasSol Inc, B Braun SE, Cardinal Health, Siemens AG, Medtronic, NeuraSignal Inc, Abbott Laboratories, METHINKS, Boston Scientific Corporation, Merck Co Inc, Heuron Co Ltd, BristolMyers Squibb Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STROKE MANAGEMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STROKE MANAGEMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Ischemic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Haemorrhagic Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STROKE MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL STROKE MANAGEMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Aidoc
  • 8.2.2 JLK
  • 8.2.3 Deepnoid Co. Ltd
  • 8.2.4 VasSol Inc
  • 8.2.5 B. Braun SE
  • 8.2.6 Cardinal Health
  • 8.2.7 Siemens AG
  • 8.2.8 Medtronic
  • 8.2.9 NeuraSignal Inc
  • 8.2.10 Abbott Laboratories
  • 8.2.11 METHINKS
  • 8.2.12 Boston Scientific Corporation
  • 8.2.13 Merck & Co. Inc
  • 8.2.14 Heuron Co. Ltd
  • 8.2.15 Bristol-Myers Squibb Company